English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Objective . To assess associations of  Chlamydia trachomatis  and  Mycoplasma genitalium  antibodies with epithelial ovarian tumors.  Methods . Plasma samples from 291 women, undergoing surgery due to suspected ovarian pathology, were analyzed with respect to  C. trachomatis  IgG and IgA, chlamydial Heat Shock Protein 60-1 (cHSP60-1) IgG and  M. genitalium  IgG antibodies. Women with borderline tumors ( n  = 12), ovarian carcinoma ( n  = 45), or other pelvic malignancies ( n  = 11) were matched to four healthy controls each.  Results . Overall, there were no associations of antibodies with EOC. However, chlamydial HSP60-1 IgG antibodies were associated with type II ovarian cancer ( P  = .002) in women with plasma samples obtained >1 year prior to diagnosis ( n  = 7).  M. genitalium  IgG antibodies were associated with borderline ovarian tumors ( P  = .01).  Conclusion . Chlamydial HSP60-1 IgG and  M. genitalium  IgG antibodies are in this study associated with epithelial ovarian tumors in some subsets, which support the hypothesis linking upper-genital tract infections and ovarian tumor development.

Chlamydia trachomatisandMycoplasma genitaliumPlasma Antibodies in Relation to Epithelial Ovarian Tumors